2 June 2026
- Its expertise in robotic surgery has been recognised at the American Urological Association Annual Meeting with the Best Surgical Video Award, placing the hospital alongside internationally renowned institutions such as Cleveland Clinic, Mayo Clinic, Johns Hopkins and Mount Sinai.
- The hospital operates one of the most advanced robotic surgery ecosystems in the Spanish healthcare system, integrating the da Vinci Xi, da Vinci SP, HUGO™ RAS and ROSA® Knee platforms.
- HM Sanchinarro has achieved pioneering milestones, including performing the first telesurgery in Europe, and has become an international training and proctoring centre for companies such as Medtronic and MicroPort.
- This represents a genuine paradigm shift in the way surgery is organised around technology, integrating clinical expertise, patient selection and outcomes analysis within a single ecosystem. It demonstrates that the hospital’s robotic surgery model is robust, innovative and internationally competitive.
HM Sanchinarro University Hospital has established itself as one of the world’s leading centres for robotic surgery and precision medicine through more than a decade of sustained investment in technological innovation, specialist training and the development of new surgical models designed to improve patient safety, surgical precision and postoperative recovery. This long-term commitment has positioned the hospital as a strategic hub for the advancement of the medicine of the future.
The hospital currently operates one of the most comprehensive and advanced robotic surgery ecosystems within the Spanish healthcare system, simultaneously integrating the da Vinci Xi, da Vinci SP (Single Port), HUGO™ RAS and ROSA® Knee platforms. This unique combination enables surgeons to tailor each procedure to the specific needs of both the patient and the operation, reinforcing a clinical model based on personalised medicine and minimally invasive surgery.
Robotic surgery is routinely applied across a broad range of specialties, including urology, general and gastrointestinal surgery, thoracic surgery, gynaecology, orthopaedics and otolaryngology, reflecting a fully integrated model in which technology serves both clinicians and patients.
“We have spent more than ten years developing our robotic surgery programme, continuously adopting every major technological advance with a single objective: improving precision, patient safety and functional recovery,” explains Dr Javier Romero-Otero, Director of the Department of Urology at HM Hospitales. “Today, we are no longer simply talking about owning advanced technology, but about having created a true robotic ecosystem capable of integrating clinical expertise, patient selection, outcomes analysis and surgical innovation within a single environment.”
A pioneering model with international recognition
The evolution of HM Sanchinarro’s robotic surgery programme has enabled the hospital to achieve several pioneering milestones, including the first telesurgery performed in both Spain and Europe within a regulated clinical research environment.
This type of procedure allows surgeons to operate remotely using advanced robotic platforms, opening up new opportunities for the future of highly complex surgery, international collaboration and access to specialist expertise regardless of geographical location.
HM Sanchinarro has also become an international centre for robotic surgery training and proctoring, working alongside some of the world’s leading medical technology companies. The hospital currently trains and certifies surgeons for organisations including Medtronic, developer of the HUGO™ RAS platform, and MicroPort, manufacturer of the Toumai robotic system. It also participates in the international accreditation process for single-port robotic surgery. “Having access to robotic systems is only part of the story. What truly matters is integrating that technology within a highly specialised programme, where the experience of the clinical team ultimately determines patient outcomes,” says Dr Romero-Otero. “This sustained commitment has enabled us to work alongside and compete within the same scientific environment as internationally recognised institutions such as Cleveland Clinic, Mayo Clinic, Johns Hopkins and Mount Sinai.”
According to Dr Iñigo Martínez, Medical Director of HM Sanchinarro University Hospital, this model represents a broader transformation in surgical practice. “This is a genuine paradigm shift—not because of the technology itself, but because of the way we organise surgery around it, integrating clinical expertise, patient selection and outcomes analysis within a single framework.”
This approach enables greater standardisation of clinical pathways, improves decision-making and supports the delivery of more precise, value-based healthcare.
Single-port surgery: a further step forward in precision and recovery
One of the most significant recent developments has been the introduction of the da Vinci SP single-port robotic system, which allows highly complex procedures to be performed through a single incision of approximately three centimetres.
This minimally invasive approach reduces surgical trauma and promotes faster recovery, with less postoperative pain, shorter hospital stays and an earlier return to normal daily activities. It is particularly valuable in reconstructive procedures, complex pelvic surgery and selected oncological interventions performed within confined anatomical spaces.”Single-port surgery not only preserves all the advantages of conventional robotic surgery but takes minimally invasive surgery even further,” explains the specialist. “Complex procedures can now be performed through a single incision, optimising functional recovery while improving the overall patient experience.”
Following its first year of clinical use, the hospital’s experience confirms that the system is safe, reproducible and particularly effective in procedures where anatomical access is especially challenging. Its greatest advantage lies in enabling complex surgery through a single incision.
Recognition at the American Urological Association Annual Meeting
HM Sanchinarro’s expertise in robotic surgery has also received significant international recognition at the latest American Urological Association (AUA) Annual Meeting, the world’s leading scientific congress in urology, where the hospital was awarded the Best Surgical Video Award for its work in robotic surgery.
The award-winning presentation compared the clinical applications and experience gained across the hospital’s different robotic platforms, further strengthening HM Sanchinarro’s international standing in advanced robotic surgery.
“This recognition carries enormous significance because we are competing alongside institutions such as Cleveland Clinic, Mayo Clinic, Johns Hopkins and Mount Sinai, centres that have historically led the development of robotic surgery worldwide,” says Dr Romero-Otero. “It demonstrates that the robotic surgery model developed at HM Sanchinarro is robust, innovative and fully competitive on the international stage.”
Alongside its clinical activity, HM Sanchinarro University Hospital plays a leading role in clinical research, advanced surgical education and the validation of emerging healthcare technologies, supporting pioneering studies that generate scientific evidence and drive further progress towards safer, more precise and increasingly personalised surgery.
Thanks to this combination of technological innovation, clinical expertise, research and education, HM Sanchinarro has established itself as a genuine international hub for robotic surgery and as one of Europe’s most advanced centres for precision medicine applied to complex surgical care.
Beyond its clinical leadership, HM Sanchinarro is equally committed to research and knowledge transfer through the continuous training of multidisciplinary teams and by welcoming healthcare professionals from Spain and abroad who wish to develop advanced robotic surgery skills. The hospital also plays an important role in validating new healthcare technologies. Through the HM Hospitales Research Foundation and its specialised research institutes, pioneering studies are conducted to evaluate the effectiveness, safety and efficiency of robotic surgery, helping to generate high-quality scientific evidence, standardise surgical techniques in this rapidly evolving field and support the responsible adoption of innovation within healthcare systems.
PR Noticias | Infosalus
